Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges Sachem Capital Corp 800 Notes due 2027 SCCG Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment CVM Q4 2024 Earnings Narrowing Losses with a 19 EPS Surprise Atlanticus Holdings ATLC Q1 2026 Earnings EPS Surges Past Estimates with 258 Beat IKT Q1 2026 Earnings Narrower Loss Beats Estimates Stock Slips on No Revenue Update Tredegar Corporation Q4 2025 Earnings Profitability Rises Despite Revenue Uncertainty STWD Q1 2026 Earnings EPS Misses Estimates by Nearly 10 OXLCN Q4 2025 Earnings EPS Misses Estimates but Stock Edges Higher EQX Q1 2026 Earnings Marginal EPS Miss as Stock Declines Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges MOGU Q2 2021 Earnings EPS Surprises to the Upside Amid Challenging Environment Longeveron Inc Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally